黄山胶囊(002817) - 2019 Q1 - 季度财报

Revenue and Profit - Revenue for Q1 2019 was CNY 77,691,919.82, an increase of 3.17% compared to CNY 75,303,393.11 in the same period last year[8] - Net profit attributable to shareholders decreased by 17.63% to CNY 8,781,777.06 from CNY 10,661,607.41 year-on-year[8] - Net profit for Q1 2019 was CNY 8,362,616.62, a decrease of 19.25% from CNY 10,356,963.12 in Q1 2018[38] - Total profit for Q1 2019 was CNY 9,768,241.97, a decrease of 20.51% from CNY 12,273,543.11 in Q1 2018[38] - Total comprehensive income for the first quarter was CNY 9,218,247.51, compared to CNY 10,981,287.50 in the previous year, reflecting a decrease of approximately 16.06%[43] - Basic earnings per share for Q1 2019 were CNY 0.10, down from CNY 0.12 in the same period last year[39] - Basic and diluted earnings per share were both CNY 0.11, down from CNY 0.13 in the same period last year, indicating a decline of 15.38%[43] Cash Flow - Net cash flow from operating activities increased by 199.15% to CNY 6,772,566.91, up from CNY 2,263,927.65 in the previous year[8] - Cash inflow from operating activities totaled CNY 54,252,653.06, an increase of 24.56% from CNY 43,423,561.06 in the previous year[46] - Total cash inflow from operating activities was CNY 54,000,716.02, an increase of 24.06% from CNY 43,391,965.44 in the previous year[50] - Total cash outflow from operating activities was CNY 46,299,741.49, up from CNY 39,679,732.20, indicating an increase of 16.54%[50] - Cash inflow from investment activities reached CNY 130,005,000.00, compared to CNY 30,325,356.16 in the previous year, representing a growth of 328.36%[47] - Net cash flow from investment activities was CNY 52,302,395.68, a turnaround from a negative CNY 82,523,071.16 in the previous year[47] - Cash and cash equivalents increased by CNY 59,437,861.35, compared to a decrease of CNY 80,304,436.60 in the same period last year[47] - The ending balance of cash and cash equivalents was CNY 250,488,908.30, up from CNY 61,004,606.45 in the previous year[51] Assets and Liabilities - Total assets at the end of the reporting period were CNY 790,186,893.57, a 1.30% increase from CNY 780,034,833.48 at the end of the previous year[8] - The total liabilities as of Q1 2019 amounted to CNY 85,209,093.40, an increase from CNY 82,994,101.41 in the previous year[35] - Total current assets increased to CNY 518,499,429.68 from CNY 505,101,665.28, reflecting a rise of about 2.76%[28] - Total liabilities increased to CNY 84,834,632.11 from CNY 83,445,188.64, indicating a growth of approximately 1.66%[29] - The company's total equity rose to CNY 705,352,261.46 from CNY 696,589,644.84, reflecting an increase of about 1.20%[30] - The company's total equity for the company reached CNY 703,733,198.32, up from CNY 694,514,950.81 year-over-year[35] - The total current liabilities rose to CNY 62,149,481.79 from CNY 60,084,153.00, an increase of approximately 3.44%[29] - The non-current liabilities decreased slightly to CNY 22,685,150.32 from CNY 23,361,035.64, a decline of approximately 2.90%[29] Research and Development - R&D expenses increased by 99.98% to CNY 169.77 million, reflecting higher investment in research projects[16] - Research and development expenses increased to CNY 3,395,750.64, representing a growth of 100.00% compared to CNY 1,698,003.13 in the previous year[36] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 14,878[12] - The company reported a net profit of CNY 270,991,447.82 in retained earnings[55] Compliance and Reporting - The company did not report any violations regarding external guarantees during the reporting period[20] - The company has not undergone an audit for the first quarter report[58] - The report was released by the legal representative Yu Chunming on April 25, 2019[59]